Useful Links
Biology
Genetics and Genomics
Medical Genetics
1. Fundamentals of Human Genetics and Genomics
2. Patterns of Inheritance
3. Cytogenetics
4. Molecular Genetics and Diagnostics
5. Clinical Genetics Practice
6. Specific Areas in Medical Genetics
7. Gene Therapy and Novel Therapeutics
8. Ethical, Legal, and Social Implications
Specific Areas in Medical Genetics
Cancer Genetics
Oncogenes
Mechanisms of Activation
Point Mutations
Gene Amplification
Chromosomal Translocations
Examples of Oncogenes
RAS Family
MYC
EGFR
HER2
Tumor Suppressor Genes
Mechanisms of Inactivation
Loss of Heterozygosity
Point Mutations
Promoter Methylation
Examples of Tumor Suppressor Genes
TP53
RB1
APC
BRCA1 and BRCA2
The Two-Hit Hypothesis
Knudson's Model
Germline vs. Somatic Mutations
Loss of Function Requirement
Hereditary Cancer Syndromes
Hereditary Breast and Ovarian Cancer
BRCA1 and BRCA2 Mutations
Cancer Risks
Management Options
Prophylactic Surgery
Lynch Syndrome
Mismatch Repair Genes
Colorectal Cancer Risk
Extracolonic Cancers
Surveillance Protocols
Familial Adenomatous Polyposis
APC Gene Mutations
Colorectal Polyps
Prophylactic Colectomy
Extracolonic Features
Li-Fraumeni Syndrome
TP53 Mutations
Multiple Cancer Types
Early Onset Cancers
Surveillance Challenges
Somatic vs. Germline Mutations in Cancer
Acquired Mutations
Inherited Predisposition
Tumor Development
Therapeutic Implications
Genomic Profiling of Tumors for Targeted Therapy
Companion Diagnostics
Biomarker Testing
Treatment Selection
FDA Approvals
Liquid Biopsy
Circulating Tumor DNA
Minimal Invasive Testing
Treatment Monitoring
Pharmacogenomics and Pharmacogenetics
Genetic Variation in Drug Metabolism
Cytochrome P450 Enzymes
CYP2D6 Polymorphisms
CYP2C19 Polymorphisms
CYP3A4 Variations
Phase I and Phase II Enzymes
Oxidation Reactions
Conjugation Reactions
Genetic Polymorphisms
Genetic Variation in Drug Targets
Receptor Polymorphisms
Transporter Variations
Drug Efficacy Impact
Clinical Applications
Warfarin Dosing
CYP2C9 Genotype
VKORC1 Genotype
Dosing Algorithms
Clopidogrel Response
CYP2C19 Genotype
Active Metabolite Formation
Alternative Therapies
Thiopurine Toxicity
TPMT Deficiency
Dose Reduction
Alternative Medications
Carbamazepine Hypersensitivity
HLA-B*5701 Association
Stevens-Johnson Syndrome
Pre-treatment Testing
Implementation in Clinical Practice
Clinical Decision Support
Electronic Health Records
Provider Education
Cost-Effectiveness
Neurogenetics
Monogenic Neurological Disorders
Huntington's Disease
HTT Gene Mutations
CAG Repeat Expansion
Anticipation Phenomenon
Predictive Testing
Spinal Muscular Atrophy
SMN1 Gene Deletions
SMN2 Copy Number
Severity Correlation
Gene Therapy
Genetics of Neurodevelopmental Disorders
Autism Spectrum Disorder
Genetic Heterogeneity
Copy Number Variants
Syndromic Forms
Environmental Factors
Intellectual Disability
X-Linked Causes
Autosomal Causes
Chromosomal Abnormalities
Metabolic Disorders
Genetics of Neurodegenerative Disorders
Alzheimer's Disease
Early-Onset Forms
Late-Onset Risk Factors
APOE Genotype
Familial Cases
Parkinson's Disease
Monogenic Forms
Risk Factor Genes
Environmental Interactions
Clinical Heterogeneity
Amyotrophic Lateral Sclerosis
Familial ALS
Sporadic ALS
C9orf72 Expansions
SOD1 Mutations
Cardiovascular Genetics
Inherited Cardiomyopathies
Hypertrophic Cardiomyopathy
Sarcomere Gene Mutations
Clinical Presentation
Sudden Death Risk
Family Screening
Dilated Cardiomyopathy
Genetic Causes
Clinical Management
Heart Failure
Transplantation
Inherited Arrhythmias
Long QT Syndrome
Ion Channel Mutations
QT Prolongation
Torsades de Pointes
Lifestyle Modifications
Brugada Syndrome
SCN5A Mutations
ST Elevation Pattern
Sudden Death Risk
ICD Implantation
Familial Hypercholesterolemia
LDLR Gene Mutations
Cholesterol Levels
Cardiovascular Risk
Treatment Options
Genetics of Congenital Heart Defects
Chromosomal Causes
Single Gene Disorders
Environmental Factors
Recurrence Risks
Inborn Errors of Metabolism
Classification of Metabolic Disorders
Amino Acid Disorders
Phenylketonuria
Maple Syrup Urine Disease
Homocystinuria
Carbohydrate Disorders
Galactosemia
Glycogen Storage Diseases
Fructose Intolerance
Lysosomal Storage Diseases
Enzyme Deficiencies
Substrate Accumulation
Progressive Symptoms
Urea Cycle Disorders
Ammonia Detoxification
Hyperammonemia
Neurological Damage
Phenylketonuria
Pathophysiology
PAH Gene Mutations
Phenylalanine Accumulation
Tyrosine Deficiency
Diagnosis and Management
Newborn Screening
Dietary Restriction
Monitoring Requirements
Pregnancy Management
Galactosemia
GALT Gene Mutations
Galactose Metabolism
Clinical Complications
Dietary Management
Lysosomal Storage Diseases
Gaucher Disease
GBA Gene Mutations
Glucocerebrosidase Deficiency
Clinical Types
Enzyme Replacement Therapy
Tay-Sachs Disease
HEXA Gene Mutations
Hexosaminidase A Deficiency
Neurodegeneration
Carrier Screening
Pompe Disease
GAA Gene Mutations
Glycogen Accumulation
Muscle Weakness
Enzyme Replacement Therapy
Urea Cycle Disorders
Ornithine Transcarbamylase Deficiency
OTC Gene Mutations
X-Linked Inheritance
Hyperammonemia
Dietary Management
Previous
5. Clinical Genetics Practice
Go to top
Next
7. Gene Therapy and Novel Therapeutics